---
title: "Chinese Regulator Approves Sino Biopharmaceul's Tulobuterol Patches for Marketing"
date: "2025-02-07 17:12:18"
summary: "Sino Biopharmaceutical's Tulobuterol Patches obtained marketing approval from the National Medical Products Administration of China, a Friday bourse filing said. The approval covers the usage of the patches for the relief of symptoms of obstructive airway diseases including dyspnoea caused by bronchial asthma, acute bronchitis, chronic bronchitis, and emphysema. Compared..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Sino Biopharmaceutical's Tulobuterol Patches obtained marketing approval from the National Medical Products Administration of China, a Friday bourse filing said.

The approval covers the usage of the patches for the relief of symptoms of obstructive airway diseases including dyspnoea caused by bronchial asthma, acute bronchitis, chronic bronchitis, and emphysema.

Compared to other traditional treatments, tulobuterol patch controls asthma symptoms more effectively and is a more convenient and safer solution for the long-term treatment of patients with obstructive airway diseases.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250207:G2465039:0/)
